1. Lacy BE, Mearin F, Chang L, et al. Bowel Disorders. Gastroenterology 2016; 150(6): 1393–407.e5.
2.
Palsson OS, Whitehead W, Törnblom H, et al. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. Gastroenterology 2020; 158(5): 1262–1273.e3.
3.
Goodoory VC, Ng CE, Black CJ, et al. Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Aliment Pharmacol Ther 2022; 55(10): 1311–1319.
4.
Ford AC, Sperber AD, Corsetti M, et al. Irritable bowel syndrome. Lancet 2020; 396(10263): 1675–1688.
5.
Keefer L, Ballou SK, Drossman DA, et al. A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction. Gastroenterology 2022; 162(1): 300–315.
6.
Ford AC, Lacy BE, Talley NJ. Irritable Bowel Syndrome. N Engl J Med 2017; 376(26): 2566–2578.
7.
Lenhart A, Ferch C, Shaw M, et al. Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists. J Neurogastroenterol Motil 2018; 24(3): 437–451.
8.
Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut 2021; 71(6): 1117–1126.
9.
Berry SK, Chey WD. Integrated Care for Irritable Bowel Syndrome: The Future Is Now. Gastroenterol Clin North Am 2021; 50(3): 713–720.
10.
Scarlata K, Eswaran S, Baker JR, et al. Utilization of Dietitians in the Management of Irritable Bowel Syndrome by Members of the American College of Gastroenterology. Am J Gastroenterol 2022; 117(6): 923–926.
11.
Böhn L, Störsrud S, Törnblom H, et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013; 108(5): 634–641.
12.
Schumann D, Langhorst J, Dobos G, et al. Randomised clinical trial: yoga vs a low-FODMAP diet in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2018; 47(2): 203–211.
13.
Peters SL, Yao CK, Philpott H, et al. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2016; 44(5): 447–459.
14.
Basnayake C, Kamm MA, Stanley A, et al. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. Lancet Gastroenterol Hepatol 2020; 5(10): 890–899.
15.
Basnayake C, Kamm MA, Stanley A, et al. Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial. Clin Gastroenterol Hepatol 2021; 20(9): 2101–2111.
16.
Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021; 70(7): 1214–1240.
17.
Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol 2021; 116(1): 17–44.
18.
Su GL, Ko CW, Bercik P, et al. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology 2020; 159(2): 697–705.
19.
Moayyedi P, Andrews CN, MacQueen G, et al. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). J Can Assoc Gastroenterol 2019; 2(1): 6–29.
20.
Tuck CJ, Reed DE, Muir JG, et al. Implementation of the low FODMAP diet in functional gastrointestinal symptoms: A real-world experience. Neurogastroenterol Motil 2020; 32(1): e13730.
21.
So D, Tuck CJ. Plant-based diets in gastrointestinal disorders: something, nothing, or everything? Lancet Gastroenterol Hepatol 2021; 6(12): 992.
